We are live on
!
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
0.3
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Associated Banc-Corp
ASB
$5.35B
| $435K | ﹤0.01% |
16,835
-1,063,095
| -98% | -$28.2M |
2025 Q4
1 quarter
|
|
627
Community Bank
CBU
$3.11B
| $435K | ﹤0.01% |
+7,412
| New | +$454K |
2026 Q1
0 quarters
|
|
628
American States Water
AWR
$3.27B
| $434K | ﹤0.01% |
5,744
+2,352
| +69% | +$173K |
2025 Q1
4 quarters
|
|
629
EverQuote
EVER
$726M
| $433K | ﹤0.01% |
28,109
-137,771
| -83% | -$2.61M |
2025 Q4
1 quarter
|
|
630
Air Products & Chemicals
APD
$65.1B
| $433K | ﹤0.01% |
+1,491
| New | +$411K |
2026 Q1
0 quarters
|
|
631
DELISTED
Theravance Biopharma
TBPH
| $432K | ﹤0.01% |
+26,647
| New | +$471K |
2026 Q1
0 quarters
|
|
632
Federal Realty Investment Trust
FRT
$9.12B
| $432K | ﹤0.01% |
4,065
-258,792
| -98% | -$27M |
2025 Q1
4 quarters
|
|
633
T-Mobile US
TMUS
$169B
| $431K | ﹤0.01% |
2,050
| – | – |
2024 Q4
5 quarters
|
|
634
National Vision
EYE
$1.35B
| $424K | ﹤0.01% |
+16,388
| New | +$445K |
2026 Q1
0 quarters
|
|
635
Amkor Technology
AMKR
$11.1B
| $418K | ﹤0.01% |
+9,282
| New | +$445K |
2026 Q1
0 quarters
|
|
636
Alarm.com
ALRM
$2.78B
| $417K | ﹤0.01% |
9,657
+2,674
| +38% | +$128K |
2025 Q2
3 quarters
|
|
637
Penske Automotive Group
PAG
$12.8B
| $413K | ﹤0.01% |
+2,765
| New | +$438K |
2026 Q1
0 quarters
|
|
638
Pediatrix Medical
MD
$2.2B
| $408K | ﹤0.01% |
+19,068
| New | +$397K |
2026 Q1
0 quarters
|
|
639
Synaptics
SYNA
$4.66B
| $406K | ﹤0.01% |
+5,794
| New | +$470K |
2026 Q1
0 quarters
|
|
640
Micron Technology
MU
$1.03T
| $397K | ﹤0.01% |
1,176
-53,540
| -98% | -$21M |
2025 Q3
2 quarters
|
|
641
Americold
COLD
$3.94B
| $396K | ﹤0.01% |
34,514
+13,697
| +66% | +$172K |
2025 Q2
3 quarters
|
|
642
Wendy's
WEN
$1.23B
| $394K | ﹤0.01% |
+56,746
| New | +$437K |
2026 Q1
0 quarters
|
|
643
ICF International
ICFI
$1.55B
| $392K | ﹤0.01% |
6,005
-10,185
| -63% | -$828K |
2025 Q1
4 quarters
|
|
644
M/I Homes
MHO
$3.12B
| $389K | ﹤0.01% |
3,180
-968
| -23% | -$130K |
2025 Q4
1 quarter
|
|
645
Winnebago Industries
WGO
$653M
| $389K | ﹤0.01% |
+12,538
| New | +$522K |
2026 Q1
0 quarters
|
|
646
LiveRamp
RAMP
$2.29B
| $386K | ﹤0.01% |
+14,556
| New | +$381K |
2026 Q1
0 quarters
|
|
647
Evertec
EVTC
$1.85B
| $383K | ﹤0.01% |
+13,556
| New | +$385K |
2026 Q1
0 quarters
|
|
648
Trupanion
TRUP
$1.17B
| $381K | ﹤0.01% |
14,859
+8,807
| +146% | +$263K |
2025 Q3
2 quarters
|
|
649
DELISTED
TopBuild
BLD
| $377K | ﹤0.01% |
+1,074
| New | +$481K |
2026 Q1
0 quarters
|
|
650
Monarch Casino & Resort
MCRI
$2.06B
| $377K | ﹤0.01% |
+3,939
| New | +$375K |
2026 Q1
0 quarters
|
|
Similar funds
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.